Herantis Pharma Oyj (HRTIS) — Strategic Asset Allocation Index
Herantis Pharma Oyj (HRTIS) has a Strategic Asset Allocation Index of 0.0% as of June 2022. Strategic assets (PP&E of €0.00 plus long-term investments of €-) total €0.00, measured against net assets of €1.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Herantis Pharma Oyj Strategic Asset Allocation Index (2013–2021)
This chart shows how Herantis Pharma Oyj's Strategic Asset Allocation Index has evolved across 8 annual periods from 2013 to 2021. As of June 2022, the index stands at 0.0%, representing strategic assets of €0.00 against net assets of €1.92 Million EUR. Explore Herantis Pharma Oyj cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Herantis Pharma Oyj (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Herantis Pharma Oyj from 2013 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Herantis Pharma Oyj stock valuation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | €0.00 | €0.00 | €- | €554.30K | ▲ +0.0 pp |
| 2020 | 0.0% | €0.00 | €0.00 | €- | €7.59 Million | ▼ -0.2 pp |
| 2019 | 0.2% | €3.69K | €3.69K | €- | €1.85 Million | ▲ +0.0 pp |
| 2017 | 0.2% | €7.72K | €6.56K | €1.16K | €4.09 Million | ▼ -0.4 pp |
| 2016 | 0.6% | €9.91K | €8.75K | €1.16K | €1.57 Million | ▲ +0.6 pp |
| 2015 | 0.0% | €2.45K | €1.29K | €1.16K | €6.00 Million | ▲ +0.0 pp |
| 2014 | 0.0% | €3.16K | €2.00K | €1.16K | €21.72 Million | ▼ -1.7 pp |
| 2013 | 1.7% | €2.00K | €2.00K | €- | €120.00K | — |